NRIP1 and colorectal carcinoma: As our molecular data linked NRIP1 to MutSα gene expression, we expected a stronger impact of RIPMSI in patients with dMLH1 CRC (i.e., tumors deficient for MutL, the other component of the MMR system; additive effect of the two alterations).